A Patient Diagnosed with Spinocerebellar Ataxia Type 5 associated with SPTBN2: Case Report
Journal of the Korean Child Neurology Society
;
: 200-203, 2017.
Article
in English
| WPRIM
| ID: wpr-79073
ABSTRACT
Spinocerebellar ataxias (SCAs) are autosomal dominant neurodegenerative disorders which disrupt the afferent and efferent pathways of the cerebellum that cause cerebellar ataxia. Spectrin beta non-erythrocytic 2 (SPTBN2) gene encodes the β-III spectrin protein with high expression in Purkinje cells that is involved in excitatory glutamate signaling through stabilization of the glutamate transporter, and its mutation is known to cause spinocerebellar ataxia type 5. Three years and 5 months old boy with delayed development showed leukodystrophy and cerebellar atrophy in brain magnetic resonance imaging (MRI). Diagnostic exome sequencing revealed that the patient has heterozygous mutation in SPTBN2 (p.Glu1251Gln) which is a causative genetic mutation for spinocerebellar ataxia type 5. With the patient's clinical findings, it seems reasonable to conclude that p.Glu1251Gln mutation of SPTBN2 gene caused spinocerebellar ataxia type 5 in this patient.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Purkinje Cells
/
Atrophy
/
Brain
/
Magnetic Resonance Imaging
/
Cerebellar Ataxia
/
Cerebellum
/
Spectrin
/
Glutamic Acid
/
Neurodegenerative Diseases
/
Spinocerebellar Ataxias
Type of study:
Diagnostic study
Limits:
Humans
/
Male
Language:
English
Journal:
Journal of the Korean Child Neurology Society
Year:
2017
Type:
Article
Similar
MEDLINE
...
LILACS
LIS